Results 131 to 140 of about 217,756 (210)

Recurrent and De Novo Cirrhosis After Liver Transplantation

Portal Hypertension &Cirrhosis, Volume 5, Issue 3, Page 207-213, September 2026.
Schematic illustrating the development of cirrhosis after liver transplantation for cirrhosis. Following transplantation of a healthy donor graft, cirrhosis may develop either through recurrence of the original liver disease (recurrent cirrhosis) or through development of a different liver disease in the transplanted graft (de novo cirrhosis). ABSTRACT
Abhinav K. Rao, Don C. Rockey
wiley   +1 more source

Course of Portal Hypertension and Its Prognostic Impact After Liver Transplantation

United European Gastroenterology Journal, Volume 14, Issue 7, September 2026.
ABSTRACT Background While portal hypertension (PH) typically resolves after liver transplantation (LT), persistence of PH may affect post‐transplant outcomes. We assessed the evolution of PH after LT and its impact on adverse outcomes. Methods We recorded clinical, laboratory, and imaging parameters of LT recipients between 2016 and 2022 in Vienna and ...
Nina Dominik, Petra Dinjar Kujundzic, Sandra Lovrekovic, Hrvoje Premec, Felix Kristandl, Lorenz Balcar, Maja Mijic, Milos Lalovac, Benedikt Silvester Hofer, Lukas Hartl, Christian Sebesta, Georg Kramer, Paul Thöne, Mattias Mandorfer, Michael Trauner, Danko Mikulic, Stipislav Jadrijevic, Georg Györi, Gabriela Berlakovich, Tajana Filipec Kanizaj, Thomas Reiberger   +20 more
wiley   +1 more source

Guideline for Medication Management of Distressing Symptoms in Older Patients Receiving End‐of‐Life Palliative Care

Journal of Evidence-Based Medicine, Volume 19, Issue 3, September 2026.
ABSTRACT Older patients receiving end‐of‐life palliative care often present with multiple geriatric syndromes, frailty, and comorbid symptom burden, resulting in a high risk of medication‐related harm. This guideline focuses on pharmacological management of distressing symptoms in older patients receiving end‐of‐life or hospice‐oriented palliative care,
Daiping Li, Yanwu Yang, Yan Zhang, Jirong Yue, Birong Dong, Meiling Ge, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University   +7 more
wiley   +1 more source

Evaluation of a Registered Nurse‐Led Outpatient Paracentesis Service for Decompensated Cirrhosis: A Retrospective Review

Journal of Evaluation in Clinical Practice, Volume 32, Issue 6, September 2026.
ABSTRACT Background Ascites is a common and debilitating complication of decompensated cirrhosis that frequently requires therapeutic paracentesis (TP) for symptom relief. Limited outpatient procedural capacity may contribute to avoidable hospital readmissions. The use of registered nurses (RNs) to perform TP remains uncommon, with few models described
Molly McDonald, Carmen Fang, Christine Song, Colina Yim, Pam Hubley, Ina Cherepaha‐Kantorovich, Sharlene Camaya, Elizabeth Lee   +7 more
wiley   +1 more source

Treatment Goals for Primary Biliary Cholangitis, an Australian Perspective

Journal of Gastroenterology and Hepatology, Volume 41, Issue 9, Page 2623-2638, September 2026.
ABSTRACT Primary biliary cholangitis (PBC) is an autoimmune liver disease that targets the small intrahepatic bile ducts with diagnosis based on elevated serum alkaline phosphatase (ALP) levels and the presence of anti‐mitochondrial antibodies. Untreated, it may run a progressive course to cirrhosis and hepatic decompensation, at which point liver ...
Simone I. Strasser, Alexander J. Thompson, Rohit Gupta, John Lubel, Janine French, Beverly Sacks, Martin Weltman   +6 more
wiley   +1 more source

The Impact of Chronic Hepatitis D Virus Infection on Health‐Related Quality of Life and Fatigue: A Real‐World International Study

Journal of Viral Hepatitis, Volume 33, Issue 9, September 2026.
ABSTRACT As little is known about the disease burden of chronic hepatitis D virus (HDV) infection, this study examined health‐related quality of life (HRQoL) and fatigue at different disease stages. This was a real‐world quantitative cross‐sectional survey of patients in Germany, Italy, Spain and the USA.
P. Lampertico, R. G. Gish, N. Reau, H. Wedemeyer, M. Buti, A. Kaushik, A. Yehoshua, C. Burk, L. Mirams, H. Ellis, T. Taylor‐Whiteley, M. Rock   +11 more
wiley   +1 more source

Characteristics of Hepatocellular Carcinoma Presention with Variceal Bleeding

, 2009
Patients with hepatocellular carcinoma may present with variceal bleeding as the initial symptoms. The aims of this study is to investigate the characteristics of such patients .
黃冠棠;李宣書;楊培銘;陳定信, HUANG, GUAN-TARN;LEE, HSUAN-SHU;YANG, PEI-MING;CHEN, DING-SHINN   +1 more
core  

Endotrophin Measured by PRO‐C6 as a Prognostic Biomarker for Liver‐Related Events in Patients With Advanced Chronic Liver Disease

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT Background & Aims Prognostic non‐invasive tests for liver‐related events in compensated cirrhosis are needed. Endotrophin, a fragment of type VI alpha 3 collagen involved in fibrosis and inflammation, has been associated with adverse outcomes in several chronic diseases.
Thomas Wiggers, Emilie Toft Skovgaard, Morten Karsdal, Jens Juul Holst, Frederik Christiansen, Andressa de Zawadzki, Diana Julie Leeming, Keyur Patel   +7 more
wiley   +1 more source

On the History of Hepatic Vein Catheterization

Liver International, Volume 46, Issue 9, September 2026.
ABSTRACT Hepatic vein catheterization (HVC) in man was first performed 80 years ago in the wake of right‐sided heart catheterization. Several new methods, recognitions and concepts followed, especially the indirect Fick‐method for determination of splanchnic blood flow. Five years passed before pressure measurements were performed and routine HVCs were
Jens Henrik Henriksen, Flemming Bendtsen, Søren Møller   +2 more
wiley   +1 more source

Long-term outcome of percutaneous transhepatic venous embolization for ectopic peristomal variceal bleeding: A case report. [PDF]

Medicine (Baltimore)
Yuan J, Zhao T, Zeng H.
europepmc   +1 more source